These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 18048806)
1. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Langsetmo L; Platt RW; Ernst P; Bourbeau J Am J Respir Crit Care Med; 2008 Feb; 177(4):396-401. PubMed ID: 18048806 [TBL] [Abstract][Full Text] [Related]
2. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study. Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040 [TBL] [Abstract][Full Text] [Related]
3. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L; Forget A; Ramachandran S Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Welte T; Miravitlles M; Hernandez P; Eriksson G; Peterson S; Polanowski T; Kessler R Am J Respir Crit Care Med; 2009 Oct; 180(8):741-50. PubMed ID: 19644045 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189 [TBL] [Abstract][Full Text] [Related]
8. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925 [TBL] [Abstract][Full Text] [Related]
9. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Calverley P; Pauwels Dagger R; Löfdahl CG; Svensson K; Higenbottam T; Carlsson LG; Ståhl E Eur Respir J; 2005 Sep; 26(3):406-13. PubMed ID: 16135720 [TBL] [Abstract][Full Text] [Related]
10. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Wang C; Bourbeau J Eur Respir J; 2010 May; 35(5):1022-30. PubMed ID: 19897555 [TBL] [Abstract][Full Text] [Related]
12. Association between incidence of acute exacerbation and medication therapy in patients with COPD. Suh DC; Lau H; La HO; Choi IS; Geba GP Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283 [TBL] [Abstract][Full Text] [Related]
13. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. FitzGerald JM; Boulet LP; Follows RM Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813 [TBL] [Abstract][Full Text] [Related]
14. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511 [TBL] [Abstract][Full Text] [Related]
15. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395 [TBL] [Abstract][Full Text] [Related]
16. Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease. Leidy NK; Murray LT; Jones P; Sethi S Ann Am Thorac Soc; 2014 Mar; 11(3):316-25. PubMed ID: 24432712 [TBL] [Abstract][Full Text] [Related]
17. Impact on patients' health status following early identification of a COPD exacerbation. Bourbeau J; Ford G; Zackon H; Pinsky N; Lee J; Ruberto G Eur Respir J; 2007 Nov; 30(5):907-13. PubMed ID: 17715163 [TBL] [Abstract][Full Text] [Related]
18. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412 [TBL] [Abstract][Full Text] [Related]
19. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease. Gershon AS; Wang L; To T; Luo J; Upshur RE COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease. Zhong N; Zheng J; Wen F; Yang L; Chen P; Xiu Q; Yao W; Sun T; Zhao Z; Shen H; Shi Y; Lin J; Li Q Curr Med Res Opin; 2012 Feb; 28(2):257-65. PubMed ID: 22046961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]